Privia Health Group Share Price (NASDAQ: PRVA)

$23.03

▲

1.22

(5.59%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Privia Health Group Stock chart to analyse performance

Privia Health Group stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$23.00
Today's High:$23.22
$23.03
0.13%
Downside
Day's Volatility :0.95%
Upside
0.82%
52 Weeks Low:$16.47
52 Weeks High:$26.09
$23.03
28.48%
Downside
52 Weeks Volatility :36.87%
Upside
11.73%

Privia Health Group Stock Returns

Period	Privia Health Group, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	0.88%	3.6%	0.0%
6 Months	-7.73%	-7.7%	0.0%
1 Year	19.39%	-12.6%	0.0%
3 Years	-41.99%	9.5%	-4.7%

Privia Health Group, Inc. Key Stats

Check Privia Health Group key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$21.81
Open	$23.11
Today's High	$23.22
Today's Low	$23.0
Market Capitalization	$2.7B
Today's Volume	$1.2M
52 Week High	$26.0899
52 Week Low	$16.47
Revenue TTM	$1.9B
EBITDA	$27.7M
Earnings Per Share (EPS)	$0.11
PE Ratio	198.27
Profit Margin	0.78%
Quarterly Earnings Growth YOY	-0.31%
Return On Equity TTM	2.71%

Stock Returns calculator for Privia Health Group Stock including INR - Dollar returns

The Privia Health Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Privia Health Group investment value today

Current value as on today

₹1,24,672

Returns

₹24,672

(+24.67%)

Returns from Privia Health Group Stock

₹19,388 (+19.39%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Privia Health Group Stock

13%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Privia Health Group Stock from India on INDmoney has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Privia Health Group, Inc.

Name
Holdings %
Name
Holdings %
BlackRock Inc
14.88%
FMR Inc
14.64%
Vanguard Group Inc
9.37%
Durable Capital Partners LP
9.36%
Rubicon Founders LLC
4.71%
Riverbridge Partners LLC
4.03%

Analyst Recommendation on Privia Health Group Stock

Rating

Trend

Buy

88%Buy

11%Hold

0%Sell

Based on 26 Wall street analysts offering stock ratings for Privia Health Group(by analysts ranked 0 to 5 stars)

Privia Health Group Share Price Target

What analysts predicted

Upside of 30.7%

Target:

$30.10

Current:

$23.03

Privia Health Group share price target is $30.10, a slight Upside of 30.7% compared to current price of $23.03 as per analysts' prediction.

Privia Health Group Stock Insights

Price Movement
In the last 7 days, PRVA stock has moved up by 4.7%
Increasing Revenue
Revenue is up for the last 6 quarters, 415.24M → 521.15M (in $), with an average increase of 4.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, 4.39M → 2.68M (in $), with an average decrease of 20.2% per quarter
PRVA vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 70.4%
PRVA vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 147.9%
Price to Sales
ForPRVA every $1 of sales, investors are willing to pay $1.5, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Privia Health Group, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$786.4M	↑ 19.58%
Net Income	$8.2M	↓ 370.83%
Net Profit Margin	1.05%	↑ 1.51%

	FY20	Y/Y Change
Revenue	$817.1M	↑ 3.91%
Net Income	$31.2M	↑ 278.99%
Net Profit Margin	3.82%	↑ 2.77%

	FY21	Y/Y Change
Revenue	$966.2M	↑ 18.25%
Net Income	$-190.6M	↓ 710.19%
Net Profit Margin	-19.73%	↓ 23.55%

	FY22	Y/Y Change
Revenue	$1.4B	↑ 40.41%
Net Income	$-12.1M	↓ 93.67%
Net Profit Margin	-0.89%	↑ 18.84%

	FY23	Y/Y Change
Revenue	$1.7B	↑ 22.19%
Net Income	$23.1M	↓ 291.3%
Net Profit Margin	1.39%	↑ 2.28%

	FY24	Y/Y Change
Revenue	$1.7B	↑ 4.74%
Net Income	$14.4M	↓ 37.67%
Net Profit Margin	0.83%	↓ 0.56%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$415.2M	↓ 5.8%
Net Income	$3.0M	↑ 5.14%
Net Profit Margin	0.72%	↑ 0.08%

	Q2 FY24	Q/Q Change
Revenue	$422.3M	↑ 1.71%
Net Income	$3.5M	↑ 16.19%
Net Profit Margin	0.82%	↑ 0.1%

	Q3 FY24	Q/Q Change
Revenue	$437.9M	↑ 3.69%
Net Income	$3.5M	↑ 1.96%
Net Profit Margin	0.81%	↓ 0.01%

	Q4 FY24	Q/Q Change
Revenue	$460.9M	↑ 5.25%
Net Income	$4.4M	↑ 24.44%
Net Profit Margin	0.95%	↑ 0.14%

	Q1 FY25	Q/Q Change
Revenue	$480.1M	↑ 4.17%
Net Income	$4.2M	↓ 4.07%
Net Profit Margin	0.88%	↓ 0.07%

	Q2 FY25	Q/Q Change
Revenue	$521.2M	↑ 8.55%
Net Income	$2.7M	↓ 36.33%
Net Profit Margin	0.52%	↓ 0.36%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$68.5M	↑ 21.28%

	FY20	Y/Y Change
Profit	$82.6M	↑ 20.61%

	FY21	Y/Y Change
Profit	$63.7M	↓ 22.91%

	FY22	Y/Y Change
Profit	$134.8M	↑ 111.71%

	FY23	Y/Y Change
Profit	$161.5M	↑ 19.82%

	FY24	Y/Y Change
Profit	$176.9M	↑ 9.51%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$40.9M	↑ 4.63%

	Q2 FY24	Q/Q Change
Profit	$42.7M	↑ 4.49%

	Q3 FY24	Q/Q Change
Profit	$45.4M	↑ 6.25%

	Q4 FY24	Q/Q Change
Profit	$48.0M	↑ 5.77%

	Q1 FY25	Q/Q Change
Profit	$45.8M	↓ 4.6%

	Q2 FY25	Q/Q Change
Profit	$47.7M	↑ 4.15%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$24.4M	↑ 364.05%
Investing Cash Flow	$-5.7M	↑ 3360.0%
Financing Cash Flow	$-10.9M	↓ 170.77%

	FY20	Y/Y Change
Operating Cash Flow	$38.9M	↑ 59.66%
Investing Cash Flow	$-380.0K	↓ 93.34%
Financing Cash Flow	$-767.0K	↓ 92.94%

	FY21	Y/Y Change
Operating Cash Flow	$55.1M	↑ 41.57%
Investing Cash Flow	$-32.8M	↑ 8525.0%
Financing Cash Flow	$213.7M	↓ 27956.71%

	FY22	Y/Y Change
Operating Cash Flow	$47.2M	↓ 14.28%
Investing Cash Flow	$-104.0K	↓ 99.68%
Financing Cash Flow	$-19.7M	↓ 109.21%

	FY23	Y/Y Change
Operating Cash Flow	$80.8M	↑ 71.17%
Investing Cash Flow	$-43.0M	↑ 41218.27%
Financing Cash Flow	$3.7M	↓ 118.83%

	FY24	Y/Y Change
Operating Cash Flow	$109.3M	↑ 35.28%
Investing Cash Flow	$-12.0M	↓ 72.13%
Financing Cash Flow	$4.3M	↑ 16.98%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-33.1M	↓ 149.23%
Investing Cash Flow	$-5.7M	↑ 15.81%
Financing Cash Flow	$475.0K	↓ 114.56%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$34.5M	↓ 204.01%
Investing Cash Flow	$1000.0K	↓ 117.5%
Financing Cash Flow	$749.0K	↑ 57.68%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$33.2M	↓ 3.81%
Investing Cash Flow	$-1000.0K	↓ 200.0%
Financing Cash Flow	$2.5M	↑ 232.58%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$74.8M	↑ 125.61%
Investing Cash Flow	$-6.3M	↑ 526.5%
Financing Cash Flow	$619.0K	↓ 75.15%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$8.0M	↓ 133.13%
Investing Cash Flow	$-89.1M	-
Financing Cash Flow	$1.9M	↓ 16.05%

Privia Health Group Technicals Summary

Sell

Neutral

Buy

Privia Health Group is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Privia Health Group, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Privia Health Group, Inc.	22.11%	-7.73%	19.39%	-41.99%	-33.73%
Tempus Ai	38.06%	48.79%	45.48%	88.27%	88.27%
Doximity, Inc.	18.52%	-0.73%	89.28%	107.86%	28.21%
Ge Healthcare Technologies Inc.	5.57%	-14.7%	-13.04%	21.9%	21.9%
Veeva Systems Inc.	-4.29%	22.99%	24.82%	57.09%	-8.43%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Privia Health Group, Inc.	198.27	198.27	NA	0.89	0.03	0.01	NA	5.57
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Privia Health Group, Inc.	Buy	$2.7B	-33.73%	198.27	0.78%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-8.43%	55.28	27.29%

About Privia Health Group, Inc.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. The company also operates accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Organization	Privia Health Group
Employees	1140
CEO	Mr. Parth Mehrotra
Industry	Healthcare

Key Management of Privia Health Group, Inc.

Name	Title
Mr. Parth Mehrotra	CEO & Director
Mr. David Mountcastle CPA, MBA	Executive VP, CFO & Principal Accounting Officer
Mr. Edward Christopher Fargis Esq.	Executive VP, General Counsel, Chief Legal Officer & Corporate Secretary
Mr. Sarath Degala	Chief Operating Officer
Mr. Chris Voigt	Executive VP & Chief Technology Officer
Mr. Robert P. Borchert	Senior Vice President of Investor Relations & Corporate Communications
Ms. Dana Fields CPA	Chief Audit & Compliance Officer
Ms. Jenny Harding	Chief People Officer
Mr. Jay Stevens	Senior VP & Chief Growth Officer
Mr. Eric J. Beyer	Executive Vice President of Medical Groups

Important FAQs about investing in PRVA Stock from India :

What is Privia Health Group share price today?

Privia Health Group share price today is $23.03 as on August 30, 2025 at 1:29 am IST at the close of the market. Privia Health Group share today touched a day high of $23.22 and a low of $23.00.

What is the 52 week high and 52 week low for Privia Health Group share?

Privia Health Group share touched a 52 week high of $26.09 and a 52 week low of $16.47. Privia Health Group stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $23.03, lower by 11.73% versus the 52 week high.

How to invest in Privia Health Group Stock (PRVA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Privia Health Group on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Privia Health Group Shares that will get you 0.0651 shares as per Privia Health Group share price of $23.03 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Privia Health Group Stock (PRVA) from India?

Indian investors can start investing in Privia Health Group (PRVA) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Privia Health Group stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Privia Health Group share’s latest price of $23.03 as on August 30, 2025 at 1:29 am IST, you will get 0.4342 shares of Privia Health Group. Learn more about fractional shares .

What are the returns that Privia Health Group has given to Indian investors in the last 5 years?

Privia Health Group stock has given -33.73% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?